Secondary Logo

Journal Logo

EDITORIAL INTRODUCTIONS

Editorial introductions

Editor(s): Ferguson, Polly J.; Haberman, Rebecca H.

Current Opinion in Rheumatology: September 2021 - Volume 33 - Issue 5 - p v
doi: 10.1097/BOR.0000000000000820
  • Free

Current Opinion in Rheumatology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of Rheumatology is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.

SECTION EDITORS

Polly J. Ferguson

figure1
Polly J. Ferguson

Dr Polly J. Ferguson received her B.S. and M.D. from the University of Iowa. She completed her Pediatric Residency and Pediatric Rheumatology & Immunology Fellowship and Post-Doctoral Research Fellowship at the University of Virginia. She is currently the Marjorie K. Lamb Professor of Pediatrics and Director of Pediatric Rheumatology at the University of Iowa Carver College of Medicine. She is an NIH funded investigator and her research program is focused on the etiology of autoinflammatory disorders including chronic recurrent multifocal osteomyelitis (CRMO) and neuroinflammation. She is an author on more than 100 peer reviewed publications, book chapters and reviews. Her work has been cited more than 5000 times.

Rebecca H. Haberman

figure2
Rebecca H. Haberman

Dr Rebecca H. Haberman is a Rheumatologist at New York University Langone Health in New York, New York. She trained in Internal Medicine and Rheumatology at the NYU Grossman School of Medicine, where she also completed a Master's in Clinical Investigation. Her research focuses on the transition from psoriasis to psoriatic arthritis, and more recently, outcomes of COVID-19 infection and vaccination in patients with immune-mediated inflammatory disease. She has received funding from the National Psoriasis Foundation and the Rheumatology Research Foundation for her work.

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.